|
Compugen Ltd. (CGEN) DCF -Bewertung
IL | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Compugen Ltd. (CGEN) Bundle
Unser (CGEN) DCF-Taschenrechner entwickelt für die Genauigkeit und ermöglicht es Ihnen, die Bewertung von Compuge Ltd. unter Verwendung realer Finanzdaten zu bewerten und gleichzeitig vollständige Flexibilität anzubieten, um alle wesentlichen Parameter für verbesserte Projektionen zu ändern.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | 2.0 | 6.0 | 7.5 | 33.5 | 52.3 | 81.7 | 127.6 | 199.4 | 311.6 |
| Revenue Growth, % | 0 | 0 | 200 | 25 | 346.12 | 56.25 | 56.25 | 56.25 | 56.25 | 56.25 |
| EBITDA | -27.0 | -31.5 | -34.6 | -35.4 | -12.5 | -24.8 | -38.8 | -60.6 | -94.7 | -148.0 |
| EBITDA, % | 100 | -1574.8 | -576.88 | -471.65 | -37.41 | -47.48 | -47.48 | -47.48 | -47.48 | -47.48 |
| Depreciation | 1.0 | .7 | .5 | .5 | .5 | 15.8 | 24.7 | 38.6 | 60.3 | 94.3 |
| Depreciation, % | 100 | 35.75 | 7.68 | 6.43 | 1.42 | 30.26 | 30.26 | 30.26 | 30.26 | 30.26 |
| EBIT | -28.0 | -32.2 | -35.1 | -35.9 | -13.0 | -25.0 | -39.0 | -61.0 | -95.3 | -148.8 |
| EBIT, % | 100 | -1610.55 | -584.57 | -478.08 | -38.83 | -47.77 | -47.77 | -47.77 | -47.77 | -47.77 |
| Total Cash | 43.9 | 124.4 | 117.8 | 83.7 | 50.7 | 52.3 | 81.7 | 127.6 | 199.4 | 311.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .3 | 2.2 | .2 | .3 | 61.3 | 32.1 | 50.2 | 78.5 | 122.6 | 191.6 |
| Account Receivables, % | 100 | 108.8 | 3.13 | 4.23 | 183.26 | 61.47 | 61.47 | 61.47 | 61.47 | 61.47 |
| Inventories | -.8 | -119.3 | -110.0 | -72.6 | .0 | -20.9 | -32.7 | -51.1 | -79.8 | -124.6 |
| Inventories, % | 100 | -5964.45 | -1832.68 | -968.65 | 0 | -40 | -40 | -40 | -40 | -40 |
| Accounts Payable | 1.1 | 1.4 | 4.6 | 1.8 | 3.5 | 29.5 | 46.0 | 71.9 | 112.4 | 175.6 |
| Accounts Payable, % | 100 | 70.65 | 77.02 | 23.64 | 10.47 | 56.35 | 56.35 | 56.35 | 56.35 | 56.35 |
| Capital Expenditure | -.2 | -.2 | -.3 | -.5 | -.2 | -2.1 | -3.3 | -5.1 | -8.0 | -12.6 |
| Capital Expenditure, % | 100 | -8.3 | -4.87 | -6.49 | -0.51406 | -4.03 | -4.03 | -4.03 | -4.03 | -4.03 |
| Tax Rate, % | -91.68 | -91.68 | -91.68 | -91.68 | -91.68 | -91.68 | -91.68 | -91.68 | -91.68 | -91.68 |
| EBITAT | -27.3 | -29.6 | -33.7 | -35.9 | -24.9 | -24.2 | -37.9 | -59.2 | -92.5 | -144.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -24.9 | 88.0 | -37.7 | -76.2 | -156.5 | 65.5 | -6.2 | -9.7 | -15.1 | -23.6 |
| WACC, % | 16.45 | 16.45 | 16.45 | 16.45 | 16.45 | 16.45 | 16.45 | 16.45 | 16.45 | 16.45 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 26.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -24 | |||||||||
| Terminal Value | -167 | |||||||||
| Present Terminal Value | -78 | |||||||||
| Enterprise Value | -52 | |||||||||
| Net Debt | -13 | |||||||||
| Equity Value | -39 | |||||||||
| Diluted Shares Outstanding, MM | 88 | |||||||||
| Equity Value Per Share | -0.45 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator with pre-filled real CGEN financials.
- Real-World Data: Historical data and forward-looking estimates (as shown in the yellow cells).
- Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe how your inputs affect Compugen's valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive Financial Data: Gain access to precise pre-loaded historical performance and future estimates for Compugen Ltd. (CGEN).
- Adjustable Forecast Parameters: Modify highlighted cells for metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Instant updates for DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Clear and concise charts and summaries to help you interpret your valuation findings.
- Suitable for All Skill Levels: A straightforward, intuitive layout designed for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Compugen Ltd.'s pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the results and utilize the insights for investment decisions regarding Compugen Ltd. (CGEN).
Why Choose Compugen Ltd. (CGEN) Calculator?
- Precision: Utilizes real Compugen financial data for reliable results.
- Versatility: Allows users to easily adjust and experiment with various inputs.
- Efficiency: Eliminate the need to create a DCF model from the ground up.
- Expert-Level: Crafted with the accuracy and functionality expected by finance professionals.
- Intuitive: Simple interface suitable for users with varying levels of financial expertise.
Who Should Use Compugen Ltd. (CGEN)?
- Investors: Gain insights and make informed decisions with our advanced analytics tools.
- Biotech Analysts: Streamline your research process with access to comprehensive data and reports.
- Consultants: Efficiently customize our resources for client projects and strategic presentations.
- Biotechnology Enthusiasts: Enhance your knowledge of the biotech industry through detailed case studies.
- Educators and Students: Utilize our resources as a hands-on learning tool in life sciences and biotechnology courses.
What the Template Contains
- Historical Data: Includes Compugen Ltd.'s (CGEN) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Compugen Ltd.'s (CGEN) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Compugen Ltd.'s (CGEN) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.